ENANTA PHARMACEUTICALS INC·4

Dec 3, 6:28 PM ET

Luly Jay R. 4

4 · ENANTA PHARMACEUTICALS INC · Filed Dec 3, 2024

Insider Transaction Report

Form 4
Period: 2024-12-01
Luly Jay R.
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2024-12-01$8.60/sh3,829$32,929806,780 total
Footnotes (1)
  • [F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit awards granted on November 20, 2020 and November 19, 2021.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES